Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
AL-амилоидоз, протекающий под маской IgG4-связанного заболевания: описание клинического случая
AL-амилоидоз, протекающий под маской IgG4-связанного заболевания: описание клинического случая
Чальцев Б.Д., Торгашина А.В. AL-амилоидоз, протекающий под маской IgG4-связанного заболевания: описание клинического случая. Терапевтический архив. 2023;95(5):425–428.
DOI: 10.26442/00403660.2023.05.202198
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
DOI: 10.26442/00403660.2023.05.202198
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В статье приводится описание уникального клинического случая AL-амилоидоза, протекающего под маской IgG4-связанного заболевания. Плазматические дискразии могут имитировать клинические и лабораторные проявления, характерные для иммуновоспалительных ревматических заболеваний, что может приводить к задержке постановки диагноза и неправильной тактике терапии.
Ключевые слова: IgG4-связанное заболевание, AL-амилоидоз, подчелюстной сиалоаденит, множественная миелома
Keywords: IgG4-related disease, AL amyloidosis, submandibular sialoadenitis, multiple myeloma
Ключевые слова: IgG4-связанное заболевание, AL-амилоидоз, подчелюстной сиалоаденит, множественная миелома
________________________________________________
Keywords: IgG4-related disease, AL amyloidosis, submandibular sialoadenitis, multiple myeloma
Полный текст
Список литературы
1. Сокол Е.В. IgG4-связанное заболевание: что мы знаем 20 лет спустя. Терапевтический архив. 2020;92(5):104-9 [Sokol EV. IgG4-related disease: what do we know after 20 years. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(5):104-9 (in Russian)]. DOI:10.26442/00403660.2020.05.000632
2. Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67(9):2466-75. DOI:10.1002/art.39205
3. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74(1):14-8. DOI:10.1136/annrheumdis-2013-204907
4. Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31(3):529‑33. DOI:10.1080/14397595.2020.1859710
5. Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020;72(1):7-19. DOI:10.1002/art.41120
6. Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019;104(3):444-55. DOI:10.3324/haematol.2018.205526
7. Сокол Е.В., Черкасова М.В., Торгашина А.В. Диагностическая ценность IgG4 сыворотки крови при IgG4-связанном заболевании: так ли она велика? Современная ревматология. 2019;13(1):52-7 [Sokol EV, Cherkasova MV, Torgashina AV. The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: and is that so great? Modern Rheumatology Journal. 2019;13(1):52-7 (in Russian)]. DOI:10.14412/1996-7012-2019-1-52-57
8. Васильев В.И., Пальшина С.Г., Павловская А.И., и др. Идиопатическая мультицентрическая болезнь Кастлемана. Терапевтический архив. 2020;92(5):78-84 [Vasilyev VI, Palshina SG, Pavlovskaya AI, et al. Idiopathic multicentric Castleman’s disease. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(5):78-84 (in Russian)]. DOI:10.26442/00403660.2020.05.000440
9. Васильев В.И., Сокол Е.В., Кокосадзе Н.В., и др. Дифференциальная диагностика болезни Эрдгейма–Честера и заболеваний, связанных с IgG4. Терапевтический архив. 2016;88(5):70-6 [Vasiliev VI, Sokol EV, Kokosadze NV, et al. The differential diagnosis of Erdheim–Chester disease and IgG4-related diseases. Terapevticheskii Arkhiv (Ter. Arkh.). 2016;88(5):70-6 (in Russian)]. DOI:10.17116/terarkh201688570-76
10. Zheng M, Zhou P, Zheng K, et al. A special subtype of POEMS syndrome: IgG4 subtype. Am J Transl Res. 2016;8(2):588-96.
11. Gauiran DTV, Marcon KM, DeMarco ML, et al. IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases. Hematology. 2020;25(1):335-40. DOI:10.1080/16078454.2020.1815130
12. Geyer JT, Niesvizky R, Jayabalan DS, et al. IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease. Mod Pathol. 2014;27(3):375-81. DOI:10.1038/modpathol.2013.159
13. Yu KH, Chan TM, Tsai PH, et al. Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease. Medicine (Baltimore). 2015;94(41):e1707. DOI:10.1097/MD.0000000000001707
14. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680. DOI:10.1097/MD.0000000000000680
15. Karim F, Clahsen-van Groningen M, van Laar JA. AA Amyloidosis and IgG4-Related Disease. N Engl J Med. 2017;376(6):599-600. DOI:10.1056/NEJMc1614275
16. Wisniowski-Yáñez A, Zavala-García G, Hernández-Molina G, et al. Amyloid A amyloidosis secondary to immunoglobulin G4-related disease. Rheumatology (Oxford). 2021;60(3):e97-8. DOI:10.1093/rheumatology/keaa467
17. Martín-Nares E, Saavedra-González V, Fagundo-Sierra R, et al. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease [published correction appears in Sci Rep. 2021 Jun 1;11(1):11959]. Sci Rep. 2021;11(1):1832. DOI:10.1038/s41598-021-81321-5
18. Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, et al. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma. Br J Haematol. 2007;137(3):240-3. DOI:10.1111/j.1365-2141.2007.06561.x
19. Dispenzieri A, Lacy MQ, Katzmann JA, et al. Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2006;107(8):3378-83. DOI:10.1182/blood-2005-07-2922
20. Papadea C, Reimer CB, Check IJ. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance. Ann Clin Lab Sci. 1989;19(1):27-37.
2. Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67(9):2466-75. DOI:10.1002/art.39205
3. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74(1):14-8. DOI:10.1136/annrheumdis-2013-204907
4. Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31(3):529‑33. DOI:10.1080/14397595.2020.1859710
5. Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020;72(1):7-19. DOI:10.1002/art.41120
6. Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019;104(3):444-55. DOI:10.3324/haematol.2018.205526
7. Sokol EV, Cherkasova MV, Torgashina AV. The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: and is that so great? Modern Rheumatology Journal. 2019;13(1):52-7 (in Russian). DOI:10.14412/1996-7012-2019-1-52-57
8. Vasilyev VI, Palshina SG, Pavlovskaya AI, et al. Idiopathic multicentric Castleman’s disease. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(5):78-84 (in Russian). DOI:10.26442/00403660.2020.05.000440
9. Vasiliev VI, Sokol EV, Kokosadze NV, et al. The differential diagnosis of Erdheim–Chester disease and IgG4-related diseases. Terapevticheskii Arkhiv (Ter. Arkh.). 2016;88(5):70-6 (in Russian). DOI:10.17116/terarkh201688570-76
10. Zheng M, Zhou P, Zheng K, et al. A special subtype of POEMS syndrome: IgG4 subtype. Am J Transl Res. 2016;8(2):588-96.
11. Gauiran DTV, Marcon KM, DeMarco ML, et al. IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases. Hematology. 2020;25(1):335-40. DOI:10.1080/16078454.2020.1815130
12. Geyer JT, Niesvizky R, Jayabalan DS, et al. IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease. Mod Pathol. 2014;27(3):375-81. DOI:10.1038/modpathol.2013.159
13. Yu KH, Chan TM, Tsai PH, et al. Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease. Medicine (Baltimore). 2015;94(41):e1707. DOI:10.1097/MD.0000000000001707
14. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680. DOI:10.1097/MD.0000000000000680
15. Karim F, Clahsen-van Groningen M, van Laar JA. AA Amyloidosis and IgG4-Related Disease. N Engl J Med. 2017;376(6):599-600. DOI:10.1056/NEJMc1614275
16. Wisniowski-Yáñez A, Zavala-García G, Hernández-Molina G, et al. Amyloid A amyloidosis secondary to immunoglobulin G4-related disease. Rheumatology (Oxford). 2021;60(3):e97-8. DOI:10.1093/rheumatology/keaa467
17. Martín-Nares E, Saavedra-González V, Fagundo-Sierra R, et al. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease [published correction appears in Sci Rep. 2021 Jun 1;11(1):11959]. Sci Rep. 2021;11(1):1832. DOI:10.1038/s41598-021-81321-5
18. Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, et al. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma. Br J Haematol. 2007;137(3):240-3. DOI:10.1111/j.1365-2141.2007.06561.x
19. Dispenzieri A, Lacy MQ, Katzmann JA, et al. Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2006;107(8):3378-83. DOI:10.1182/blood-2005-07-2922
20. Papadea C, Reimer CB, Check IJ. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance. Ann Clin Lab Sci. 1989;19(1):27-37.
2. Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67(9):2466-75. DOI:10.1002/art.39205
3. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74(1):14-8. DOI:10.1136/annrheumdis-2013-204907
4. Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31(3):529‑33. DOI:10.1080/14397595.2020.1859710
5. Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020;72(1):7-19. DOI:10.1002/art.41120
6. Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019;104(3):444-55. DOI:10.3324/haematol.2018.205526
7. Сокол Е.В., Черкасова М.В., Торгашина А.В. Диагностическая ценность IgG4 сыворотки крови при IgG4-связанном заболевании: так ли она велика? Современная ревматология. 2019;13(1):52-7 [Sokol EV, Cherkasova MV, Torgashina AV. The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: and is that so great? Modern Rheumatology Journal. 2019;13(1):52-7 (in Russian)]. DOI:10.14412/1996-7012-2019-1-52-57
8. Васильев В.И., Пальшина С.Г., Павловская А.И., и др. Идиопатическая мультицентрическая болезнь Кастлемана. Терапевтический архив. 2020;92(5):78-84 [Vasilyev VI, Palshina SG, Pavlovskaya AI, et al. Idiopathic multicentric Castleman’s disease. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(5):78-84 (in Russian)]. DOI:10.26442/00403660.2020.05.000440
9. Васильев В.И., Сокол Е.В., Кокосадзе Н.В., и др. Дифференциальная диагностика болезни Эрдгейма–Честера и заболеваний, связанных с IgG4. Терапевтический архив. 2016;88(5):70-6 [Vasiliev VI, Sokol EV, Kokosadze NV, et al. The differential diagnosis of Erdheim–Chester disease and IgG4-related diseases. Terapevticheskii Arkhiv (Ter. Arkh.). 2016;88(5):70-6 (in Russian)]. DOI:10.17116/terarkh201688570-76
10. Zheng M, Zhou P, Zheng K, et al. A special subtype of POEMS syndrome: IgG4 subtype. Am J Transl Res. 2016;8(2):588-96.
11. Gauiran DTV, Marcon KM, DeMarco ML, et al. IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases. Hematology. 2020;25(1):335-40. DOI:10.1080/16078454.2020.1815130
12. Geyer JT, Niesvizky R, Jayabalan DS, et al. IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease. Mod Pathol. 2014;27(3):375-81. DOI:10.1038/modpathol.2013.159
13. Yu KH, Chan TM, Tsai PH, et al. Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease. Medicine (Baltimore). 2015;94(41):e1707. DOI:10.1097/MD.0000000000001707
14. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680. DOI:10.1097/MD.0000000000000680
15. Karim F, Clahsen-van Groningen M, van Laar JA. AA Amyloidosis and IgG4-Related Disease. N Engl J Med. 2017;376(6):599-600. DOI:10.1056/NEJMc1614275
16. Wisniowski-Yáñez A, Zavala-García G, Hernández-Molina G, et al. Amyloid A amyloidosis secondary to immunoglobulin G4-related disease. Rheumatology (Oxford). 2021;60(3):e97-8. DOI:10.1093/rheumatology/keaa467
17. Martín-Nares E, Saavedra-González V, Fagundo-Sierra R, et al. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease [published correction appears in Sci Rep. 2021 Jun 1;11(1):11959]. Sci Rep. 2021;11(1):1832. DOI:10.1038/s41598-021-81321-5
18. Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, et al. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma. Br J Haematol. 2007;137(3):240-3. DOI:10.1111/j.1365-2141.2007.06561.x
19. Dispenzieri A, Lacy MQ, Katzmann JA, et al. Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2006;107(8):3378-83. DOI:10.1182/blood-2005-07-2922
20. Papadea C, Reimer CB, Check IJ. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance. Ann Clin Lab Sci. 1989;19(1):27-37.
________________________________________________
2. Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67(9):2466-75. DOI:10.1002/art.39205
3. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74(1):14-8. DOI:10.1136/annrheumdis-2013-204907
4. Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31(3):529‑33. DOI:10.1080/14397595.2020.1859710
5. Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020;72(1):7-19. DOI:10.1002/art.41120
6. Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019;104(3):444-55. DOI:10.3324/haematol.2018.205526
7. Sokol EV, Cherkasova MV, Torgashina AV. The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: and is that so great? Modern Rheumatology Journal. 2019;13(1):52-7 (in Russian). DOI:10.14412/1996-7012-2019-1-52-57
8. Vasilyev VI, Palshina SG, Pavlovskaya AI, et al. Idiopathic multicentric Castleman’s disease. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(5):78-84 (in Russian). DOI:10.26442/00403660.2020.05.000440
9. Vasiliev VI, Sokol EV, Kokosadze NV, et al. The differential diagnosis of Erdheim–Chester disease and IgG4-related diseases. Terapevticheskii Arkhiv (Ter. Arkh.). 2016;88(5):70-6 (in Russian). DOI:10.17116/terarkh201688570-76
10. Zheng M, Zhou P, Zheng K, et al. A special subtype of POEMS syndrome: IgG4 subtype. Am J Transl Res. 2016;8(2):588-96.
11. Gauiran DTV, Marcon KM, DeMarco ML, et al. IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases. Hematology. 2020;25(1):335-40. DOI:10.1080/16078454.2020.1815130
12. Geyer JT, Niesvizky R, Jayabalan DS, et al. IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease. Mod Pathol. 2014;27(3):375-81. DOI:10.1038/modpathol.2013.159
13. Yu KH, Chan TM, Tsai PH, et al. Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease. Medicine (Baltimore). 2015;94(41):e1707. DOI:10.1097/MD.0000000000001707
14. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680. DOI:10.1097/MD.0000000000000680
15. Karim F, Clahsen-van Groningen M, van Laar JA. AA Amyloidosis and IgG4-Related Disease. N Engl J Med. 2017;376(6):599-600. DOI:10.1056/NEJMc1614275
16. Wisniowski-Yáñez A, Zavala-García G, Hernández-Molina G, et al. Amyloid A amyloidosis secondary to immunoglobulin G4-related disease. Rheumatology (Oxford). 2021;60(3):e97-8. DOI:10.1093/rheumatology/keaa467
17. Martín-Nares E, Saavedra-González V, Fagundo-Sierra R, et al. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease [published correction appears in Sci Rep. 2021 Jun 1;11(1):11959]. Sci Rep. 2021;11(1):1832. DOI:10.1038/s41598-021-81321-5
18. Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, et al. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma. Br J Haematol. 2007;137(3):240-3. DOI:10.1111/j.1365-2141.2007.06561.x
19. Dispenzieri A, Lacy MQ, Katzmann JA, et al. Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2006;107(8):3378-83. DOI:10.1182/blood-2005-07-2922
20. Papadea C, Reimer CB, Check IJ. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance. Ann Clin Lab Sci. 1989;19(1):27-37.
Авторы
Б.Д. Чальцев*, А.В. Торгашина
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва, Россия
*bodya92@inbox.ru
Nasonova Research Institute of Rheumatology, Moscow, Russia
*bodya92@inbox.ru
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва, Россия
*bodya92@inbox.ru
________________________________________________
Nasonova Research Institute of Rheumatology, Moscow, Russia
*bodya92@inbox.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.